GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS (IST:ONCSM) » Definitions » PEG Ratio

Oncosem Onkolojik Sistemlernayi ve Ticaret AS (IST:ONCSM) PEG Ratio : N/A (As of Mar. 31, 2025)


View and export this data going back to 2023. Start your Free Trial

What is Oncosem Onkolojik Sistemlernayi ve Ticaret AS PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Oncosem Onkolojik Sistemlernayi ve Ticaret AS's PE Ratio without NRI is 0.00. Oncosem Onkolojik Sistemlernayi ve Ticaret AS's 5-Year EBITDA growth rate is 0.00%. Therefore, Oncosem Onkolojik Sistemlernayi ve Ticaret AS's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Oncosem Onkolojik Sistemlernayi ve Ticaret AS's PEG Ratio or its related term are showing as below:



IST:ONCSM's PEG Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.06
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Oncosem Onkolojik Sistemlernayi ve Ticaret AS PEG Ratio Historical Data

The historical data trend for Oncosem Onkolojik Sistemlernayi ve Ticaret AS's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncosem Onkolojik Sistemlernayi ve Ticaret AS PEG Ratio Chart

Oncosem Onkolojik Sistemlernayi ve Ticaret AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
PEG Ratio
Get a 7-Day Free Trial - - - - -

Oncosem Onkolojik Sistemlernayi ve Ticaret AS Quarterly Data
Dec19 Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Oncosem Onkolojik Sistemlernayi ve Ticaret AS's PEG Ratio

For the Medical Devices subindustry, Oncosem Onkolojik Sistemlernayi ve Ticaret AS's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oncosem Onkolojik Sistemlernayi ve Ticaret AS's PEG Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Oncosem Onkolojik Sistemlernayi ve Ticaret AS's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Oncosem Onkolojik Sistemlernayi ve Ticaret AS's PEG Ratio falls into.


;
;

Oncosem Onkolojik Sistemlernayi ve Ticaret AS PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Oncosem Onkolojik Sistemlernayi ve Ticaret AS's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Oncosem Onkolojik Sistemlernayi ve Ticaret AS  (IST:ONCSM) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Oncosem Onkolojik Sistemlernayi ve Ticaret AS PEG Ratio Related Terms

Thank you for viewing the detailed overview of Oncosem Onkolojik Sistemlernayi ve Ticaret AS's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Oncosem Onkolojik Sistemlernayi ve Ticaret AS Business Description

Traded in Other Exchanges
N/A
Address
Mutlukent Mah. 1988 Cad. No: 12, Cankaya, Ankara, TUR
Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS is specialized in the production of equipment and medical devices used in cancer treatment.

Oncosem Onkolojik Sistemlernayi ve Ticaret AS Headlines

No Headlines